Use of alkylphosphoric acid compounds for combatting psoriasis disorders
CA 2026278 C · Owner: Asta Medica Aktiengesellschaft · Inventors: Eibl, Hansjorg; Engel, Jurgen; Unger, Clemens
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The use of alkylphosphoric acid compounds of formula I R - Y - PO2 - X - R1 I, where in formula I R represents a saturated or unsaturated hydrocarbon radical with 12 to 24 carbon atoms or where R represents the group -CH2-CHR3-CH2-Z-R4 and R3 is a C1-C6alkoxy group or a C1-C6-alkoxymethyl group Z represents, oxygen or sulphur and R4 represents a C1-C24-alkyl radical X is an oxygen atom, NH or NR2 and Y is an oxygen atom or NH R1 is a C1-C8-alkyl group, or where R1 represents a C2-C8alkyl group which is unsaturated and/or substituted by halogen, amino, C1-C6-alkylamino, di-C1-C6-alkylamino tri-, C1-C6-alkylamino, hydroxy, carboxy C3-C8-cycloalkyl or, phenyl for the preparation of a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 26, 1990 and granted April 30, 1996. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended September 26, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 26, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.